Next Issue
Previous Issue

Table of Contents

Diagnostics, Volume 4, Issue 1 (March 2014), Pages 1-26

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list.
  • You may sign up for e-mail alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Readerexternal link to open them.
View options order results:
result details:
Displaying articles 1-3
Export citation of selected articles as:

Editorial

Jump to: Research

Open AccessEditorial Acknowledgement to Reviewers of Diagnostics in 2013
Diagnostics 2014, 4(1), 12; doi:10.3390/diagnostics4010012
Received: 28 February 2014 / Accepted: 28 February 2014 / Published: 28 February 2014
PDF Full-text (30 KB) | HTML Full-text | XML Full-text
Abstract The editors of Diagnostics would like to express their sincere gratitude to the following reviewers for assessing manuscripts in 2013. [...] Full article

Research

Jump to: Editorial

Open AccessArticle An Improved Neutral a-Glucosidase Assay for Assessment of Epididymal Function—Validation and Comparison to the WHO Method
Diagnostics 2014, 4(1), 1-11; doi:10.3390/diagnostics4010001
Received: 6 November 2013 / Revised: 19 December 2013 / Accepted: 6 January 2014 / Published: 9 January 2014
PDF Full-text (194 KB) | HTML Full-text | XML Full-text
Abstract
Neutral a-glucosidase (NAG) activity in human seminal plasma is an important indicator for epididymis functionality. In the present study, the classic World Health Organization (WHO) method has been adapted to enhance assay robustness. Changes include modified enzyme reaction buffer composition and usage [...] Read more.
Neutral a-glucosidase (NAG) activity in human seminal plasma is an important indicator for epididymis functionality. In the present study, the classic World Health Organization (WHO) method has been adapted to enhance assay robustness. Changes include modified enzyme reaction buffer composition and usage of an alternative enzyme inhibitor for background correction (glucose instead of castanospermine). Both methods have been tested in parallel on 144 semen samples, obtained from 94 patients/donors and 50 vasectomized men (negative control), respectively. Passing-Bablok regression analysis demonstrated equal assay performance. In terms of assay validation, analytical specificity, detection limit, measuring range, precision, and cut-off values have been calculated. These data confirm that the adapted method is a reliable, improved tool for NAG analysis in human semen. Full article
(This article belongs to the collection Feature Papers)
Figures

Open AccessArticle Development of a Hybrid Nanoprobe for Triple-Modality MR/SPECT/Optical Fluorescence Imaging
Diagnostics 2014, 4(1), 13-26; doi:10.3390/diagnostics4010013
Received: 29 January 2014 / Revised: 28 February 2014 / Accepted: 4 March 2014 / Published: 10 March 2014
Cited by 1 | PDF Full-text (1435 KB) | HTML Full-text | XML Full-text
Abstract
Hybrid clinical imaging is an emerging technology, which improves disease diagnosis by combining already existing technologies. With the combination of high-resolution morphological imaging, i.e., MRI/CT, and high-sensitive molecular detection offered by SPECT/PET/Optical, physicians can detect disease progression at an early stage [...] Read more.
Hybrid clinical imaging is an emerging technology, which improves disease diagnosis by combining already existing technologies. With the combination of high-resolution morphological imaging, i.e., MRI/CT, and high-sensitive molecular detection offered by SPECT/PET/Optical, physicians can detect disease progression at an early stage and design patient-specific treatments. To fully exploit the possibilities of hybrid imaging a hybrid probe compatible with each imaging technology is required. Here, we present a hybrid nanoprobe for triple modality MR/SPECT/Fluorescence imaging. Our imaging agent is comprised of superparamagnetic iron oxide nanoparticles (SPIONs), labeled with 99mTc and an Alexa fluorophore (AF), together forming 99mTc-AF-SPIONs. The agent was stable in human serum, and, after subcutaneous injection in the hind paw of Wistar rats, showed to be highly specific by accumulating in the sentinel lymph node. All three modalities clearly visualized the imaging agent. Our results show that a single imaging agent can be used for hybrid imaging. The use of a single hybrid contrast agent permits simultaneous hybrid imaging and, more conventionally, allow for single modality imaging at different time points. For example, a hybrid contrast agent enables pre-operative planning, intra-operative guidance, and post-operative evaluation with the same contrast agent. Full article
(This article belongs to the collection Hybrid Imaging in Medicine)

Journal Contact

MDPI AG
Diagnostics Editorial Office
St. Alban-Anlage 66, 4052 Basel, Switzerland
diagnostics@mdpi.com
Tel. +41 61 683 77 34
Fax: +41 61 302 89 18
Editorial Board
Contact Details Submit to Diagnostics
Back to Top